Astrazeneca PLC/ US0463531089 /
14/05/2024 21:59:57 | Diferencia -0.39 | Volumen | Bid0:00:01 | Ask22:02:00 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
77.04USD | -0.50% | 325,155 Volumen de negocios: 19.69 millones |
60.00Volumen de oferta: 2 | 77.05Tamaño/ Volumen/ Formato de Ask: 4 | 238.34 mil millonesUSD | - | 20.06 |
GlobeNewswire
1:12
Contact Hagens Berman by May 21, 2024 Deadline to Join Class Action Against Shoals Technologies Grou...
GlobeNewswire
1:09
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel ...
GlobeNewswire
1:08
Contact Hagens Berman by May 31, 2024 Deadline to Join Class Action Against Luna Innovations (LUNA)
GlobeNewswire
1:01
Contact Hagens Berman by May 20, 2024 Deadline to Join Class Action Against The Chemours Company (CC...
GlobeNewswire
1:00
Hudson Acquisition I Corp. and Aiways Automobile Europe GmbH Enter into Letter Agreement for Busines...
GlobeNewswire
0:46
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Exscientia p.l.c Investors to Secure Counsel Before Impo...
GlobeNewswire
0:33
UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT...
GlobeNewswire
0:30
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Globe Life Inc. f/k/a Torchmark Corporation Investor...
GlobeNewswire
0:10
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Li Auto Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
14/05
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losse...
GlobeNewswire
14/05
Daily Journal Corporation Announces Financial Results for the six months ended March 31, 2024
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página